
|Articles|August 26, 2016
Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top news of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/biosimilar-naming-convention-debate-highlights-spe" target="_blank">View the story "Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Halfway There Is Nowhere
2
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
3
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
4
Combined Food Policies, Including Labeling and Advertising Bans, Plausibly Reduce Childhood Obesity
5


















































































































